Peripheral naïve CD8+ T cells as a predictive biomarker of response to lenvatinib plus an anti-PD-1 antibody in advanced hepatocellular carcinoma: a biomarker study

Cancer Commun (Lond). 2022 Aug 22. doi: 10.1002/cac2.12350. Online ahead of print.
No abstract available

Publication types

  • Letter